Compare stocks

Up to 2 stocks side by side – every figure with value, threshold and date. No overall score, no ordering by result.

2 stocks selected – remove one to add another. Up to 4 stocks with Premium. Premium

Comparison: MRNA, NVAX
Figure MRNA × Moderna Health Care NVAX × Novavax Health Care
Quality checksfrom the annual figures, without price-based criteria
Quality 2 of 8 criteria with data met 3 of 7 criteria with data met · 1 without data
Growth 1 of 6 criteria with data met · 1 without data 3 of 5 criteria with data met · 2 without data
Dividend 0 of 1 criteria with data met · 6 without data 0 of 1 criteria with data met · 6 without data
Financial strength 4 of 6 criteria with data met 1 of 6 criteria with data met
Key figuresValue, distance to the fixed threshold, sector median alongside
Net marginThreshold: above 10% −145.2% Distance −155.2 ppSector median 12.9% (63 stocks) 39.2% Distance +29.2 ppSector median 12.9% (63 stocks)
Operating marginThreshold: above 15% −158.1% Distance −173.1 ppSector median 17.0% (54 stocks) 40.3% Distance +25.3 ppSector median 17.0% (54 stocks)
Gross marginThreshold: above 40% 55.3% Distance +15.3 ppSector median 61.8% (49 stocks) 93.5% Distance +53.5 ppSector median 61.8% (49 stocks)
Return on equityThreshold: above 15% −32.6% Distance −47.6 ppSector median 12.8% (54 stocks) – not computable (negative equity)
Free cash flow marginThreshold: above 10% −106.2% Distance −116.2 ppSector median 14.5% (61 stocks) −22.3% Distance −32.3 ppSector median 14.5% (61 stocks)
Profitable yearsThreshold: 5 of 5 2 of 5 1 of 5
Years with positive free cash flowThreshold: 3 of 3 0 of 3 0 of 3
Revenue growth 5 yearsThreshold: above 5% per year +19.3% per year Distance +14.3 ppSector median +7.8% per year (60 stocks) +18.8% per year Distance +13.8 ppSector median +7.8% per year (60 stocks)
EPS growth 5 yearsThreshold: above 5% per year not available not available
EquityThreshold: above 0 8.7B USD −127.8M USD
Equity ratioThreshold: above 30% 70.1% Distance +40.1 ppSector median 44.2% (63 stocks) −10.9% Distance −40.9 ppSector median 44.2% (63 stocks)
Debt / equityThreshold: at most 1.0 0.07 Distance −0.93Sector median 0.66 (50 stocks) – not computable (negative equity)
Piotroski F-ScoreThreshold: at least 7 2 of 9 Distance −5 pointsSector median 6 of 9 (47 stocks) 5 of 9 Distance −2 pointsSector median 6 of 9 (47 stocks)
DepthEarnings quality, consistency, valuation in words, trailing 12 months and sector rank
Cash flow ÷ profit Earnings quality, covered from 1.0 – no profit in the latest fiscal year negative cash flowed out despite a profitas of fiscal year 2025
Loss years Consistency, last up to 10 fiscal years 8 of 10 as of fiscal year 2025 9 of 10 as of fiscal year 2025
Years with lower revenue Consistency, last up to 10 fiscal years 5 of 9 as of fiscal year 2025 4 of 10 as of fiscal year 2025
Years without a dividend cut Dividend per share, split-adjusted not available not available
P/E against its own 5-year median Valuation against its own history not available not available
Net margin 12 months trailing 12 months per SEC not available −18.6% 12 months to Sep 30, 2026
Quarterly revenue vs. a year earlier latest quarter +29.2% grown for 3 quarters in a row −3.0%
Quarterly earnings vs. a year earlier latest quarter not available not available
Sector rank net margin 0 to 100, 100 = strongest value 4 99
Sector rank return on equity 0 to 100, 100 = strongest value 5 not available
Sector rank revenue growth (5 yrs) 0 to 100, 100 = strongest value 94 91
ChartPosition in words – distances only when signed in
position relative to the 200-day line more than 10% above As of Nov 20, 2026 more than 10% below As of Nov 20, 2026
Dividend and fiscal year
Dividend paidin the last 5 fiscal years no dividend no dividend
Latest annual figures Fiscal year to Dec 31, 2025 Fiscal year to Dec 31, 2025

How is this made? · Figures from the annual reports (SEC) · As of Nov 22, 2026 · not investment advice

↑ ↓ select · Enter open · Esc close